Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression - Wikidata - awgldk - TriplyDB

Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression

Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression

http://www.wikidata.org/entity/Q28275200

about

Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma Early events during neoplastic progression in Barrett's esophagus The p53 circuit board Reprimo tissue-specific expression pattern is conserved between zebrafish and human.Identification of a DNA methylome profile of esophageal squamous cell carcinoma and potential plasma epigenetic biomarkers for early diagnosis.Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer Plasma DNA methylation of Wnt antagonists predicts recurrence of esophageal squamous cell carcinoma.Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma.LARP7 is a potential tumor suppressor gene in gastric cancer.Reprimo (RPRM) is a novel tumor suppressor in pituitary tumors and regulates survival, proliferation, and tumorigenicity.Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line.Barrett's esophagus: can biomarkers predict progression to malignancy?DNA methylation as a biomarker in breast cancer.Epigenetic biomarkers in esophageal cancer.Reprimo, a Potential p53-Dependent Tumor Suppressor Gene, Is Frequently Hypermethylated in Estrogen Receptor α-Positive Breast Cancer.tp53-dependent G2 arrest mediator candidate gene, Reprimo, is down-regulated by promoter hypermethylation in pediatric acute myeloid leukemia.Genomics of Esophageal Cancer and Biomarkers for Early Detection.Identification of a lncRNA involved functional module for esophageal cancer subtypes.Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response.CpG island methylation profile of pancreatic intraepithelial neoplasia.The relationship between DNA methylation and Reprimo gene expression in gastric cancer cells.Loss of Reprimo and S100A2 expression in human gastric adenocarcinoma.The Reprimo Gene Family: A Novel Gene Lineage in Gastric Cancer with Tumor Suppressive Properties

P2860

Q24632246-6509F203-4042-43A7-A3F3-B13B9576A06D Q26825349-A36CCCD0-B4A4-44F5-9C4D-49D123B1F397 Q28259725-C97A8A7F-A4C4-40B2-A329-B506B52AEF4E Q33745928-18EA00ED-3501-49A6-89F7-DFBD6498440E Q33933511-1DCAF2FA-EB0C-43AA-B3F7-C7581B878A58 Q34047716-4D5C594E-CC3B-474B-9FBA-CA24B215479B Q35606943-322FC4CA-7BFC-4B11-8FA1-E6C55DD21B9C Q35666522-CF545C71-0B85-4B2B-A945-7B613057B7DD Q36247023-33330E8B-8B43-40EF-89BE-0FD9871DCA04 Q36467344-20D92B27-A538-4BCD-BAB8-F360B03C67C4 Q36489832-33B9B4FD-5EE7-4A49-A127-D0EAF9B1246E Q37345836-12182143-CE30-4FB3-999D-769D1C39BA1A Q37620392-C035598E-5AA4-49C7-8FF7-053599D4AA38 Q37992481-EC9B5E1F-9540-4DBF-9026-E531BB24329A Q38623918-4F28917C-AC7E-43B5-BA34-CFF8F713A776 Q38915689-A8AEC4A8-8A7D-4A64-9571-DC55B0124074 Q38940530-5523C295-19F7-4EF4-9F19-2222BB0E2CDA Q39476144-9FF323FC-B805-4086-9112-5BE46C4684B3 Q40419898-042FB8B8-3EC6-4231-95BE-E1C75E59846D Q42053166-4D5A3459-1F4A-494F-856C-F923D5330CAF Q47193788-577DE422-73DC-46DF-8C1B-9A89449F1CB7 Q53295389-C1537A57-36C3-4594-BFFA-6D19A2955693 Q57129087-46B5F586-CFC1-4F5B-9E89-38F8C9C7EFEE

P2860

Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression

http://www.wikidata.org/entity/Q28275200

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Reprimo methylation is a poten ...... phageal neoplastic progression

@ast

Reprimo methylation is a poten ...... phageal neoplastic progression

@en

Reprimo methylation is a poten ...... phageal neoplastic progression

@nl

type

label

Reprimo methylation is a poten ...... phageal neoplastic progression

@ast

Reprimo methylation is a poten ...... phageal neoplastic progression

@en

Reprimo methylation is a poten ...... phageal neoplastic progression

@nl

prefLabel

Reprimo methylation is a poten ...... phageal neoplastic progression

@ast

Reprimo methylation is a poten ...... phageal neoplastic progression

@en

Reprimo methylation is a poten ...... phageal neoplastic progression

@nl

P1433

Q28275200-6A025E57-F639-40F7-BBEB-D92736DBC5F2

P1476

Q28275200-0B536CC0-4275-43F7-869A-F52DBBC486DB

P2093

Q28275200-1F149086-AF53-4DF1-85D8-4BE61A05046E

Q28275200-23BE49BD-29B8-4FF5-BD41-3412209DA158

Q28275200-32A5D10D-ADB1-410E-9B11-A5D8EB1C6C1D

Q28275200-33402C9A-4A1D-4202-A059-02704F460D52

Q28275200-612BC6E1-7B73-4A2A-A70C-D3C766C33E04

Q28275200-6CE2A9BB-41F0-4D8A-A4BF-29C368E837C1

Q28275200-764A568C-F1F7-4C47-841F-DAC5EB1A9AE6

Q28275200-82C61F58-FD78-4B58-B435-9AA790E9CDF8

Q28275200-9A9B755B-79A0-4902-8CC3-373FC26DF047

Q28275200-A1354635-A255-46B5-B2B3-E30EDE393707

P304

Q28275200-6595DD9E-5BE7-4B23-810C-6742DB037B29

P31

Q28275200-AF9A1704-62B8-41D4-9A93-C5D2BE4C54E6

P356

Q28275200-20DFA3A8-8D1C-46EF-946F-9D475D392018

P407

Q28275200-F19E404D-664D-48AA-9669-49A7040206AD

P433

Q28275200-D1B1C89A-3AE7-4694-89C0-0EAECC4A85B0

P478

Q28275200-3AA6B10E-0601-4666-8CC7-8824D49FED41

P577

Q28275200-99898F35-A64E-4A55-960B-F1FF130EC4E8

P5875

Q28275200-12751F7F-46B3-4EC6-B266-D4A3124AA6F5

P698

Q28275200-D1C478A1-8BB3-484F-A937-7D7D7389F85E

P921

Q28275200-D1008661-5025-468D-AEBF-FAFEC25AEAF2

P356

1078-0432.CCR-06-1781

P1433

Clinical Cancer Research

P1476

Reprimo methylation is a poten ...... phageal neoplastic progression

@en

P2093

Bogdan C Paun

http://www.w3.org/2001/XMLSchema#string

Bruce D Greenwald

http://www.w3.org/2001/XMLSchema#string

Fumiaki Sato

http://www.w3.org/2001/XMLSchema#string

James P Hamilton

http://www.w3.org/2001/XMLSchema#string

Jian Yang

http://www.w3.org/2001/XMLSchema#string

John M Abraham

http://www.w3.org/2001/XMLSchema#string

Stephen J Meltzer

http://www.w3.org/2001/XMLSchema#string

Suna Wang

http://www.w3.org/2001/XMLSchema#string

Takatsugu Kan

http://www.w3.org/2001/XMLSchema#string

Tetsuo Ito

http://www.w3.org/2001/XMLSchema#string

P304

6637-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-06-1781

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6675929

http://www.w3.org/2001/XMLSchema#string

P698

17121882

http://www.w3.org/2001/XMLSchema#string

P921